Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Enzyme Responsible for the Benefits of Caloric Restriction Identified

By LabMedica International staff writers
Posted on 14 Oct 2009
Researchers are beginning to define the molecular basis for the improvement in health and increase in life expectancy induced by reducing caloric intake and maintaining a reduced calorie diet.

Investigators at University College London (United Kingdom) genetically engineered a line of "knockdown" mice that lacked the gene for the enzyme ribosomal S6 Kinase 1 (S6K1). More...
S6K1 is a component of the nutrient-responsive mTOR (mammalian target of rapamycin) signaling pathway, which guides the organism's response to changing levels of nutrients.

Results comparing normal and S6K1 knockdown mice were published in the October 2, 2009, issue of the journal Science. They showed that at an age of 600 days (the mouse equivalent of middle age) female knockout mice were leaner, and had stronger bones than did the normal females. The female knockdown mice did not show the usual age-related decline in insulin sensitivity. They performed better at motor performance tasks and were more inquisitive and exploratory. On average, the female knockout mice lived for 950 days, over 160 days longer than the control group. While the male knockout mice demonstrated the same overall better health characteristics, they did not experience the extended lifespan.

"Blocking the action of the S6K1 protein helps prevent a number of age-related conditions in female mice," explained senior author Dr. Dominic Withers, professor of diabetes and endocrinology research at University College London. "The mice lived longer and were leaner, more active and generally healthier than the control group. We added "life to their years" as well as "years to their lives"."

Related Links:
University College London



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.